Quarterly report pursuant to sections 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Condensed Consolidated Statements Of Operations        
REVENUES $ 360,338 $ 0 $ 594,834 $ 0
Cost of sales 144,691 0 288,761 0
Gross profit 215,647 0 306,073 0
Research and development expenses 1,940,637 56,607 2,201,131 443,188
Loss on sale of research and development inventory 0 0 0 (1,934,630)
Plasma center operating expenses 489,300 450,527 1,327,761 1,191,243
General and administrative expenses 1,034,530 261,030 2,446,043 932,248
TOTAL OPERATING EXPENSES 3,464,467 768,164 5,974,935 4,501,309
LOSS FROM OPERATIONS (3,248,820) (768,164) (5,668,862) (4,501,309)
OTHER INCOME (EXPENSE), NET 3,073 (212,913) 1,471 (768,130)
LOSS BEFORE INCOME TAXES (3,245,747) (981,077) (5,667,391) (5,269,439)
State income tax benefit 0 0 617,615 320,765
NET LOSS $ (3,245,747) $ (981,077) $ (5,049,776) $ (4,948,674)
NET LOSS PER SHARE - BASIC AND DILUTED $ (0.70) $ (2.79) $ (1.27) $ (14.08)
WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC AND DILUTED 4,654,303 351,535 3,988,005 351,535